Medical Journals

Identification of the Insulin Signaling Cascade in the Regulation of Alpha-class Glutathione S-transferase Expression in Primary Cultured Rat Hepatocytes.

Authors:
  • Kim Sang K
  • Abdelmegeed Mohamed A
  • Novak Raymond F

From: Institute of Environmental Health Sciences, Wayne State University, 2727 South Avenue, Room 4000, Detroit, MI 48201, USA.

The Journal of pharmacology and experimental therapeutics

  • Publish Date: Mar 2006
  • ISSN: 0022-3565
  • Volume: 316
  • Issue: 3
  • Pages: 1255-61
  • Medium: Print
  • Language: English
  • Citation (JAMA): Kim Sang K, Abdelmegeed Mohamed A, Novak Raymond F, et al. Identification of the Insulin Signaling Cascade in the Regulation of Alpha-class Glutathione S-transferase Expression in Primary Cultured Rat Hepatocytes.. J. Pharmacol. Exp. Ther. Mar 2006;316:1255-61

Abstract

We reported previously that insulin elevated alpha-class glutathione S-transferase (GSTs) protein levels in primary cultured rat hepatocytes (Kim et al., 2003b). In contrast, glucagon down-regulated alpha- and pi-class GST expression, and mechanistic research implicated cAMP and protein kinase A in this process (Kim et al., 2003b). The present study examines the signaling pathways involved in the regulation of alpha-class GST in response to insulin in primary cultured rat hepatocytes. Protein levels of GSTA1/2 and GSTA3/5 and activity of GST toward 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD) were increased in an insulin concentration-dependent manner. Treatment of cells with the phosphatidylinositol 3-kinase (PI3K) inhibitors wortmannin and LY294002 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one] or rapamycin, an inhibitor of mammalian target of rapamycin and ribosomal p70 S6 kinase (p70S6K) phosphorylation, or with an adenovirus containing green fluorescent protein and a dominant-negative and kinase-dead Akt, effectively inhibited the insulin-mediated increase in alpha-class GST expression and GST activity toward NBD. In contrast, PD98059 (2’-amino-3’-methoxyflavone), an inhibitor of mitogen-activated protein kinase kinase, SP600125 (1,9-pyrazoloanthrone), an inhibitor of c-Jun N-terminal kinase, SB203580 [4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)1H-imadazole], an inhibitor of p38 mitogen-activated protein kinase, or bisindolylmaleimide, a broad spectrum inhibitor of protein kinase C, did not inhibit the insulin-mediated increase in alpha-class GST protein levels in hepatocytes. These results show that PI3K/Akt/p70S6K signaling is active in the insulin-mediated up-regulation of the antioxidant defense system and that low insulin levels, as encountered in diabetes, potentially increase the susceptibility of hepatocytes to xenobiotic-mediated and/or oxidative stress-mediated damage.

Mesh Headings (Keywords): 1-Phosphatidylinositol 3-Kinase, Animals, Cells, Cultured, Dose-Response Relationship, Drug, Epoxide Hydrolases, Glutathione Transferase, Hepatocytes, Insulin, Male, Protein Kinase C, Proto-Oncogene Proteins c-akt, Rats, Rats, Sprague-Dawley, Ribosomal Protein S6 Kinases, 70-kDa, Signal Transduction


Check for Full Text / PubMed Unique Identifier (PMID): 16293713


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.